GSK plc (LON:GSK) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of GSK plc (LON:GSK) have been given a consensus recommendation of “Moderate Buy” by the seven brokerages that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating and five have given a buy rating to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is GBX 1,805.83 ($21.97).

Several analysts recently commented on the stock. Berenberg Bank reduced their price target on shares of GSK from GBX 1,820 ($22.14) to GBX 1,600 ($19.47) and set a “buy” rating for the company in a research report on Friday, November 29th. JPMorgan Chase & Co. reiterated an “underweight” rating on shares of GSK in a research note on Tuesday, January 7th.

Insider Buying and Selling

In related news, insider Jonathan Symonds purchased 1,500 shares of the stock in a transaction dated Friday, December 20th. The shares were acquired at an average cost of GBX 1,315 ($16.00) per share, with a total value of £19,725 ($23,999.27). Insiders bought 8,658 shares of company stock valued at $11,950,792 over the last ninety days. Corporate insiders own 1.61% of the company’s stock.

GSK Price Performance

GSK stock opened at GBX 1,363.26 ($16.59) on Tuesday. The company has a current ratio of 0.82, a quick ratio of 0.73 and a debt-to-equity ratio of 123.04. The company has a market capitalization of £55.62 billion, a P/E ratio of 1,206.42, a PEG ratio of 1.24 and a beta of 0.31. The business has a 50 day simple moving average of GBX 1,343.53 and a 200-day simple moving average of GBX 1,468.96. GSK has a twelve month low of GBX 1,282.50 ($15.60) and a twelve month high of GBX 1,823.50 ($22.19).

GSK Dividend Announcement

The company also recently announced a dividend, which was paid on Thursday, January 9th. Stockholders of record on Thursday, November 14th were issued a GBX 15 ($0.18) dividend. This represents a dividend yield of 1.03%. The ex-dividend date was Thursday, November 14th. GSK’s payout ratio is 5,309.73%.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.